Literature DB >> 24756993

Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?

Jeremy Chataway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24756993     DOI： 10.1177/1352458514531088

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

Review 1.  Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis.

Authors:  Simona Lattanzi; Claudia Cagnetti; Maura Danni; Leandro Provinciali; Mauro Silvestrini
Journal:  J Neurol       Date:  2017-05-10       Impact factor: 4.849

2.  Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.

Authors:  Peter Joseph Jongen; Ioanna Stavrakaki; Bernard Voet; Erwin Hoogervorst; Erik van Munster; Wim H Linssen; Ludovicus G Sinnige; Wim I Verhagen; Leo H Visser; Ruud van der Kruijk; Freek Verheul; Jan Boringa; Marco Heerings; Werner Gladdines; Fredrik Lönnqvist; Pieter Gaillard
Journal:  J Neurol       Date:  2016-06-07       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.